Summary
GlobalData's clinical trial report, “Zika Virus Infections Global Clinical Trials Review, H2, 2018" provides an overview of Zika Virus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Zika Virus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Valneva SE
Sanofi
QPS Holdings LLC
Inovio Pharmaceuticals Inc
GeneOne Life Science Inc
Emergent BioSolutions Inc
Codagenix Inc
Bharat Biotech Ltd
Alternate Health Corp
Ala Wai Pharma Inc
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Zika Virus Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Zika Virus Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Zika Virus Infections Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 52
Contact Us 53
Source 53
List of Tables
Zika Virus Infections Therapeutics, Global, Clinical Trials by Region, 2018* 7
Zika Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Zika Virus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Zika Virus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Zika Virus Infections Therapeutics Clinical Trials, Europe, Top Countries, 2018* 12
Zika Virus Infections Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Zika Virus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Zika Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Zika Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Zika Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Zika Virus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 19
Zika Virus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Zika Virus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Zika Virus Infections Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Zika Virus Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Zika Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Zika Virus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Zika Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Zika Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Zika Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
Zika Virus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
List of Figures
Zika Virus Infections Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Zika Virus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Zika Virus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Zika Virus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Zika Virus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Zika Virus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Zika Virus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15
Zika Virus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Zika Virus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Zika Virus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 19
Zika Virus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Zika Virus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Zika Virus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Zika Virus Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Zika Virus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Zika Virus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Zika Virus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Zika Virus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Zika Virus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
GlobalData Methodology 52
